Xeris Biopharma

(NASDAQ) XERS

Current Price$6.36

Market Cap$1.11B

Since IPO (2021)+172%

5 Year+87%

1 Year+31%

1 Month+8%

Xeris Biopharma Financials at a Glance

Market Cap

$1.11B

Revenue (TTM)

$314.85M

Net Income (TTM)

$12.01M

EPS (TTM)

$0.07

P/E Ratio

98.17

Dividend

$0.00

Beta (Volatility)

1.26 (Average)

Dividend

$0.00

Beta (Volatility)

1.26 (Average)

Price

$6.36

Volume

68,246

Open

$6.42

Price

$6.36

Volume

68,246

Open

$6.42

Previous Close

$6.43

Daily Range

$6.29 - $6.44

52-Week Range

$4.30 - $10.08

Dividend

$0.00

Beta (Volatility)

1.26 (Average)

Price

$6.36

Volume

68,246

Open

$6.42

Previous Close

$6.43

Daily Range

$6.29 - $6.44

52-Week Range

$4.30 - $10.08

XERS News

Two people in white lab coats looking at a computer display

Why Xeris Biopharma Stock Zoomed 7% Higher on Wednesday

Eric VolkmanDec 31, 2025

Xeris (XERS) Q2 Revenue Jumps 49%

Motley Fool Markets TeamAug 7, 2025

XERS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Xeris Biopharma

Industry

Pharmaceuticals

Sector

Health Care

Employees

435

CEO

John Patrick Shannon, Jr.

Website

www.xerispharma.com

Headquarters

Chicago, IL 60601, US

XERS Financials

Key Financial Metrics (TTM)

Gross Margin

82%

Operating Margin

11%

Net Income Margin

Return on Equity

Return on Capital

13%

Return on Assets

Earnings Yield

1.02%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.11B

Shares Outstanding

172.64M

Volume

68.25K

Avg. Volume

1.93M

Financials (TTM)

Gross Profit

$238.43M

Operating Income

$24.90M

EBITDA

$12.71M

Operating Cash Flow

$28.63M

Capital Expenditure

$696.00K

Free Cash Flow

$27.93M

Cash & ST Invst.

$111.04M

Total Debt

$37.76M

Xeris Biopharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$83.13M

+38.3%

Gross Profit

$69.84M

+35.9%

Gross Margin

84.02%

N/A

Market Cap

$1.11B

N/A

Market Cap/Employee

$2.82M

N/A

Employees

394

N/A

Net Income

$2.23M

+124.2%

EBITDA

$11.13M

+806.0%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$74.42M

+135.4%

Accounts Receivable

$56.30M

+21.5%

Inventory

$74.23M

+40.9%

Long Term Debt

$31.06M

-87.6%

Short Term Debt

$6.27M

-65.3%

Return on Assets

3.06%

N/A

Return on Invested Capital

13.13%

N/A

Free Cash Flow

$9.54M

+195.0%

Operating Cash Flow

$9.87M

+198.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BHVNBiohaven Ltd.

BHVNBiohaven Ltd.$9.07+0.44%

JANXJanux Therapeutics, Inc.

JANXJanux Therapeutics, Inc.$14.47-0.96%

ABCLAbCellera Biologics Inc.

ABCLAbCellera Biologics Inc.$4.43-7.13%

MAZEMaze Therapeutics, Inc.

MAZEMaze Therapeutics, Inc.$26.40-2.08%

IMCRImmunocore Holdings plc

IMCRImmunocore Holdings plc$28.84-0.40%

HRMYHarmony Biosciences Holdings, Inc.

HRMYHarmony Biosciences Holdings, Inc.$30.79-0.13%

SIONSionna Therapeutics, Inc.

SIONSionna Therapeutics, Inc.$42.35-1.79%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AIIORobo.ai

AIIORobo.ai$6.05+1.32%

NOKNokia

NOKNokia$14.49-0.01%

POETPoet Technologies

POETPoet Technologies$19.88+0.38%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.70-0.01%

FRMIFermi

FRMIFermi$7.24+0.21%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.94-0.03%

SNAPSnap

SNAPSnap$5.35-0.05%

Questions About XERS

What is the current price of Xeris Biopharma?

Xeris Biopharma is trading at $6.36 per share.

What is the 52-week range for Xeris Biopharma?

Over the past 52 weeks, Xeris Biopharma has traded between $4.30 and $10.08.

How much debt does Xeris Biopharma have?

As of the most recent reporting period, Xeris Biopharma reported total debt of $258.55M.

How much cash does Xeris Biopharma have on hand?

Xeris Biopharma reported $111.75M in cash and cash equivalents in its most recent financial results.

What is Xeris Biopharma’s dividend yield?

Xeris Biopharma does not currently have a dividend yield.

Xeris Biopharma

Xeris Biopharma Financials at a Glance

XERS News

Why Xeris Biopharma Stock Zoomed 7% Higher on Wednesday

Xeris (XERS) Q2 Revenue Jumps 49%

XERS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Xeris Biopharma

XERS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Xeris Biopharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About XERS

What is the current price of Xeris Biopharma?

What is the 52-week range for Xeris Biopharma?

How much debt does Xeris Biopharma have?

How much cash does Xeris Biopharma have on hand?

What is Xeris Biopharma’s dividend yield?

Premium Investing Services